{"preliminary_commentary":{"by_channel":{"x_thread":2,"bluesky_thread":1},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build."},"free_build":{"available":false},"name":"ADEPPT","nct_id":"NCT05673187","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=adeppt-nct05673187. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":"ADEPPT","arms":[{"description":"Adagrasib to be administered at a dose of 600 mg orally, twice daily until progression or unacceptable toxicity.","label":"Treatment Arm","type":"EXPERIMENTAL"}],"collaborators":["Mirati Therapeutics Inc."],"completion_date":{"date":"2026-12","type":"ESTIMATED"},"conditions":["NSCLC Stage IV","KRAS P.G12C"],"enrollment":{"count":68,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"Adagrasib","otherNames":[],"type":"DRUG"}],"last_update":"2026-09-03","lead_sponsor":"ETOP IBCSG Partners Foundation","official_title":"A Multicentre, Single-arm Phase II Trial of Adagrasib in Patients With KRASG12C-mutant NSCLC, Including the Elderly (≥70 Years) or Patients With Poor Performance Status","overall_status":"ACTIVE_NOT_RECRUITING","phases":["PHASE2"],"primary_completion_date":{"date":"2025-07-28","type":"ACTUAL"},"primary_outcomes":[{"measure":"Objective Response Rate (ORR) per RECIST v1.1, assessed at 12 weeks.","timeFrame":"From date of enrolment until 12 weeks post-enrolment"}],"references":[],"start_date":{"date":"2023-06-12","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Adagrasib in Patients With KRASG12C-mutant NSCLC Who Are Elderly or Have Poor Performance Status","url":"https://clinicaltrials.gov/study/NCT05673187"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/adeppt-nct05673187"}